Table of Contents Understanding Weight Loss Injections and Reproductive Health Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), as well as tirzepatide (Mounjaro, a dual GIP/GLP-1 receptor agonist), have become increasingly prescribed for weight management in the UK
Treatments with a family of lipid-lowering drugs known as fibrates (e.g., fenofibrate, bezofibrate) have been associated with an increased excretion of betaine in the urine and a rise in homocysteine concentration in the blood of patients with diabetes mellitus or metabolic syndrome (125, 126)
In Lebers hereditary optic neuritis contraindication, B12 can cause blindness
Jardiance and metformin are often used together because they lower blood sugar in different ways, and combination therapy may be used if one medication alone isnt enough
Prescriptions to young people for two GLP-1 medications semaglutide and liraglutide (Saxenda) jumped 700% between 2022 and 2024